When to use bispecifics for AML
Ibrutinib combination therapy in CLL: overview of the data so far
The evolving treatment landscape in multiple myeloma and its implications for clinical practice
The evolving genomic landscape of ALL: molecular genetics, profiling and classification
Anjali Advani et al.
Exciting novel AML treatment: venetoclax plus cobimetinib or idasanutlin in elderly patients